You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/PRNewswire/Kodiak+reboots+tarcocimab+tedromer+development+program+following+strong+positive+results+in+Phase+3+diabetic+retinopathy+GLOW+study+and+following+dialogue+with+US+regulatory+authorities+on+a+regulator/22363413.html